← Back to Clinical Trials
Recruiting NCT06472986

NCT06472986 Activity-Based Therapy and Transcutaneous Spinal Cord Stimulation After Spinal Cord Injury (ABT-TCSCS)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06472986
Status Recruiting
Phase —
Sponsor University Health Network, Toronto
Condition Spinal Cord Injuries
Study Type INTERVENTIONAL
Enrollment 24 participants
Start Date 2022-10-07
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Activity-based therapy and transcutaneous spinal cord stimulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 24 participants in total. It began in 2022-10-07 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The ABT-TCSCS study investigates how feasible and beneficial are activity-based therapy and transcutaneous spinal cord stimulation on improving of arm and hand recovery after cervical spinal cord injury.

Eligibility Criteria

Inclusion Criteria: * Individuals with chronic traumatic and non-traumatic cervical SCI (ASIA classification A-incomplete\*\*, B, C, D) between C1-C8 * Adults more than 18 years old * At least 6 months post-spinal cord injury * A score of 2 - 15 on the upper extremity motor score of the ISNCSCI * A score between 5 - 40 on GRASSP Version 1 Strength on at least one side * Individuals who are medically stable Exclusion Criteria: * Individuals with any other upper extremity deficit * Unable to provide informed consent * Unable to participate in an intensive rehabilitation outpatient program * Spasticity that limits the range of motion greater than 50% for the elbow or wrist

Contact & Investigator

Central Contact

Urvashy Gopaul, PhD

✉ urvashy.gopaul@uhn.ca

📞 416-597-3422

Principal Investigator

Sukhvinder Kalsi-Ryan

PRINCIPAL INVESTIGATOR

Toronto Rehabilitation Institute

Frequently Asked Questions

Who can join the NCT06472986 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Spinal Cord Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06472986 currently recruiting?

Yes, NCT06472986 is actively recruiting participants. Contact the research team at urvashy.gopaul@uhn.ca for enrollment information.

Where is the NCT06472986 trial being conducted?

This trial is being conducted at Toronto, Canada.

Who is sponsoring the NCT06472986 clinical trial?

NCT06472986 is sponsored by University Health Network, Toronto. The principal investigator is Sukhvinder Kalsi-Ryan at Toronto Rehabilitation Institute. The trial plans to enroll 24 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology